GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societal CDMO Inc (FRA:RAH) » Definitions » Gross-Profit-to-Asset %

Societal CDMO (FRA:RAH) Gross-Profit-to-Asset % : 19.97% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Societal CDMO Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Societal CDMO's annualized Gross Profit for the quarter that ended in Dec. 2023 was €28.24 Mil. Societal CDMO's average Total Assets over the quarter that ended in Dec. 2023 was €141.36 Mil. Therefore, Societal CDMO's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 19.97%.


Societal CDMO Gross-Profit-to-Asset % Historical Data

The historical data trend for Societal CDMO's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societal CDMO Gross-Profit-to-Asset % Chart

Societal CDMO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.78 11.02 15.46 15.04 11.50

Societal CDMO Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.14 5.82 11.91 9.99 19.97

Competitive Comparison of Societal CDMO's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societal CDMO's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Societal CDMO's Gross-Profit-to-Asset % falls into.



Societal CDMO Gross-Profit-to-Asset % Calculation

Societal CDMO's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=16.633/( (148.626+140.736)/ 2 )
=16.633/144.681
=11.50 %

Societal CDMO's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=28.236/( (141.984+140.736)/ 2 )
=28.236/141.36
=19.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Societal CDMO Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Societal CDMO's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Societal CDMO (FRA:RAH) Business Description

Traded in Other Exchanges
Address
1 E. Uwchlan Avenue, Suite 112, Exton, PA, USA, 19341
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.

Societal CDMO (FRA:RAH) Headlines

No Headlines